Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)
Recruiting
N/A
Interventional Study
HIV Prevention
HIV Related Stigma
PrEP Adherence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 29
- Sex
- Male
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 108 (estimated)
- Sponsor
- Institute of HIV Research and Innovation Foundation, Thailand · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-29 years
* Male sex at birth
* Self-identify as transgender woman/female spectrum
* HIV-negative (laboratory confirmed)
* Recent condomless sex
* Able to understand Thai
* Not on PrEP or poorly adherent (≤3 pills/week)
Exclusion Criteria:
* Serious cognitive or psychi…
Contacts